The Journal of the Royal Society for the Promotion of Health

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfe, E.S.
Right arrow Articles by Wolfe, W.W.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Journal of the Royal Society for the Promotion of Health, Vol. 117, No. 3, 151-155 (1997)
DOI: 10.1177/146642409711700304
© 1997 Royal Society for the Promotion of Health

Discussion of the controversies associated with prostate cancer screening

E.S. Wolfe

Medical College of Ohio School of Nursing PO Box 10008 Toledo OH 43699-0008 USA

W.W. Wolfe

Education Technology and Human Resource Development University of Toledo Toledo OH USA

Early detection of prostate cancer through screening seems to provide the best hope of control or possibly cure of the disease. Unfortunately, controversy and confusion surround the screening guidelines. Specifically, the controversy involves whether the screening of asymptomatic men, particularly those under age 50, should be recommended.

To date, there have been no randomised clinical trials which have demonstrated that screening for prostate cancer reduces mortality or increases life expectancy.

The lack of evidence regarding the benefits of prostate screening and the risk of adverse effects make it important for clinicians to provide information to interested patients regarding the possible consequences before they take part in screening endeavours. Other health care professionals must be proactive in becoming informed about the entire prostate screening issue.

Key Words: Early detection • health care costs • informed consent • prostate cancer • screening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?